作者：
Van Cutsem, E. [1]
;
Prenen, H. [2]
;
D'Haens, G. [3]
;
Bennouna, J. [4]
;
Carrato, A. [5]
;
Ducreux, M. [6]
;
Bouche, O. [7]
;
Sobrero, A. [8]
;
Latini, L. [9]
;
Staines, H. [10]
;
Oum'Hamed, Z. [11]
;
Dressler, H. [12]
;
Studeny, M. ;
Capdevila, J.
作者单位：
Boehringer Ingelheim GmbH & Co KG, Div Med, Dept Clin Dev, Vienna, Austria
[1]
Inst Gustave Roussy, Gustave Roussy Canc Campus, Paris, France
[2]
Vall dHebron Univ Hosp, VHIO, Barcelona, Spain
[3]
Ctr Rene Gauducheau, Dept Med Oncol, F-44035 Nantes, France
[4]
Boehringer Ingelheim France SAS, Med & Drug Regulatory Affairs, Reims, France
[5]
Boehringer Ingelheim GmbH & Co KG, Global Pharmacovigilance, Ingelheim, Germany
[6]
Macerata Hosp, Oncol Unit, Macerata, Italy
[7]
Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands
[8]
Ramon & Cajal Univ Hosp, Dept Med Oncol, Madrid, Spain
[9]
Univ Hosp Leuven, Digest Oncol, Leuven, Belgium
[10]
CHU Reims, Dept Digest Oncol, Reims, France
[11]
San Martino Hosp, Dept Med Oncol, Genoa, Italy
[12]
发布时间
2015-11-26
换一批
